Companies See Boost in Hair Care Spending Due to GLP-1 Side Effect

The boost in GLP-1 usage means more people seeing these side effects, which in turn creates new demand for hair care products ...
Fast Company

Employers are spending more on GLP-1 drugs, but the ROI is already here

GLP-1 weight loss treatment can be pricey. But employers who cover the treatments could end up saving on employee medical expenses overall. The finding is according to a new analysis of health ...
AOL

Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?

Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion. Over the ...
STAT

The GLP-1 telehealth boom, Senate investigation of MA plans, and the fall of a cancer startup

It’s relatively simple to go online and get a prescription for a GLP-1 medication for diabetes or obesity thanks to dozens of companies that have stepped in to fill demand for the potentially ...
The New England Journal of Medicine

GLP-1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...